Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares MLH1 promoter methylation (sporadic versus Lynch mismatch repair loss), Mismatch repair proteins (MLH1, MSH2, MSH6, PMS2), dMMR (mismatch repair deficiency by IHC), MSI-high (microsatellite instability by PCR or sequencing) and the tag subtype-page.
Shares A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors, EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Partic, WRN inhibitors: a second synthetic-lethal win for mismatch-repair cancers, MLH1 promoter methylation (sporadic versus Lynch mismatch repair loss) and the tag subtype-page.
Shares Lynch syndrome, Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Histopathology & immunohistochemistry, Germline (hereditary) testing and the tag subtype-page.
Shares Brachytherapy, Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam), Carboplatin and the tag subtype-page.
Shares Hysterectomy, Brachytherapy, IMRT / IGRT (modern external beam) and the tag subtype-page.
Shares Histopathology & immunohistochemistry, Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam), Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Pembrolizumab and the tag subtype-page.
Shares Paclitaxel / nab-paclitaxel, IMRT / IGRT (modern external beam), Pembrolizumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.